From: Economic impact of generic antiretrovirals in France for HIV patients’ care: a simulation between 2019 and 2023
Year
Mean (2019-M€)
SD
95% BCI
1
190.19
1.28
[188.33; 192.35]
2
382.43
1.99
[380.10; 386.02]
3
569.95
2.76
[566.49; 575.29]
4
785.23
3.58
[781.18; 793.12]
5
993.05
5.19
[987.36; 1004.82]